- Home
- ZVRA vs OABI Comparison
ZVRA vs OABI Comparison
Compare ZVRA & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- OABI
- Stock Information
- Founded
- ZVRA 2006
- OABI 2012
- Country
- ZVRA United States
- OABI United States
- Employees
- ZVRA N/A
- OABI N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- ZVRA Health Care
- OABI Health Care
- Exchange
- ZVRA Nasdaq
- OABI Nasdaq
- Market Cap
- ZVRA 458.5M
- OABI 388.5M
- IPO Year
- ZVRA 2015
- OABI N/A
- Fundamental
- Price
- ZVRA $8.15
- OABI $3.22
- Analyst Decision
- ZVRA Strong Buy
- OABI Strong Buy
- Analyst Count
- ZVRA 7
- OABI 4
- Target Price
- ZVRA $21.20
- OABI $9.00
- AVG Volume (30 Days)
- ZVRA 492.6K
- OABI 448.8K
- Earning Date
- ZVRA 11-12-2024
- OABI 11-12-2024
- Dividend Yield
- ZVRA N/A
- OABI N/A
- EPS Growth
- ZVRA N/A
- OABI N/A
- EPS
- ZVRA N/A
- OABI N/A
- Revenue
- ZVRA $24,489,000.00
- OABI $20,409,000.00
- Revenue This Year
- ZVRA N/A
- OABI N/A
- Revenue Next Year
- ZVRA $384.62
- OABI $78.61
- P/E Ratio
- ZVRA N/A
- OABI N/A
- Revenue Growth
- ZVRA 47.85
- OABI N/A
- 52 Week Low
- ZVRA $4.20
- OABI $3.16
- 52 Week High
- ZVRA $9.76
- OABI $6.55
- Technical
- Relative Strength Index (RSI)
- ZVRA 45.71
- OABI 32.70
- Support Level
- ZVRA $7.61
- OABI $3.16
- Resistance Level
- ZVRA $8.10
- OABI $3.29
- Average True Range (ATR)
- ZVRA 0.37
- OABI 0.13
- MACD
- ZVRA -0.02
- OABI -0.02
- Stochastic Oscillator
- ZVRA 40.30
- OABI 9.09
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.